Who are Benchsci's investors?

Benchsci's investors include Inovia Capital, Generation Investment Management, Gradient Ventures, TCV, 500 Global, Afore Capital, Creative Destruction Lab (CDL), F-Prime Capital and 4 more.

Where is Benchsci headquartered?

Benchsci is headquartered in Toronto, US.

Benchsci

Toronto, US · Founded 2015 · 211 employees on LinkedIn · 12 known investors

Find your way into Benchsci

627 people in our graph share verified history with the Benchsci team — schools, employers, funds. One of them is your warm intro.

Juriaan Duizendstraalunlockedknows Liran Belenzon · together at Interdisciplinary Center (overlapped)

×2knows the team · via Interdisciplinary Center

×3knows the team · via Creative Destruction Lab

×4knows the team · via University of Toronto

knows the team · via Benchsci

knows the team · via University of Toronto - Rotman School of Management

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.

AI & Machine Learning Biotech Data & Infrastructure Digital Health Healthtech

Founders & leadership

Benchsci was founded in 2015 by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung, and David Chen.

David Qixiang Chen, PhDinCo-Founder, Chief Innovation Officer (CINO), Director of AI2020–2020

Elvis WiandainCo-founder · Chief Data Officer

Liran Belenzon inFounder and CEOHe previously served as a commander in the Israel Defense Forces and founded an e-commerce B2B marketplace in Israel; he earned an MBA from the University of Toronto's Rotman School of Management.

Tom Leung inCo-founder & Chief Science OfficerTom Leung is Co-founder and Chief Science Officer of BenchSci, which develops AI-powered tools for preclinical drug discovery by extracting experimental evidence from scientific literature to help researchers select reagents and model systems.

David CheninCo-founder

Investors · 12

Inovia Capital✓ verifiedMontreal · $250K – $8M

Generation Investment Management✓ verifiedLondon

Gradient Ventures✓ verifiedSan Francisco · $100K – $10M

TCV✓ verifiedMenlo Park · $10M – $500M

500 GlobalSan Francisco · $150K

Afore CapitalSan Francisco · $500K – $2M

Creative Destruction Lab (CDL)Toronto · $50K – $250K

F-Prime CapitalCambridge · $3M – $10M

FounderFuelMontreal · $88K

Golden Venture PartnersToronto

Golden VenturesToronto · $500K – $2.5M

Two Small Fish VenturesToronto · $1M – $3M

Frequently asked questions

What does Benchsci do?: BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.
Who founded Benchsci?: Benchsci was founded by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung, David Chen in 2015.
Who are Benchsci's investors?: Benchsci's investors include Inovia Capital, Generation Investment Management, Gradient Ventures, TCV, 500 Global, Afore Capital, Creative Destruction Lab (CDL), F-Prime Capital and 4 more.
Where is Benchsci headquartered?: Benchsci is headquartered in Toronto, US.